In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, Veeva Systems, discusses clinical data trends for 2025 and simplifying management ...

Two of Bambusa’s bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in ...

Insights from Prothena's Q4 2024 call highlight 2025 milestones: pivotal trial results for birtamimab & Alzheimer's programs.

- Average microdystrophin expression of 110% (N=3) and significant improvements in multiple additional muscle health ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.